Page 339 - Read Online
P. 339

Page 10 of 14                                  Velasquillo et al. Plast Aesthet Res 2020;7:31  I  http://dx.doi.org/10.20517/2347-9264.2020.30

                   establishing criteria for hMSC potency. Stem Cells 2015;33:1878-91.
               8.   Ben Nasr M, Vergani A, Avruch J, Liu L, Kefaloyianni E, et al. Co-transplantation of autologous MSC delays islet allograft rejection and
                   generates a local immunoprivileged site. Acta Diabetol 2015;52:917-27.
               9.   Ferreira ML, Silva PC, Alvarez Silva LH, Bonfim DC, Conilho Macedo Müller LC, et al. Heterologous mesenchymal stem cells
                   successfully treat femoral pseudarthrosis in rats. J Transl Med 2012;10:51.
               10.   Rodriguez RL, Frazier T, Bunnell BA, Mouton CA, March KL, et al. Arguments for a different regulatory categorization and framework
                   for stromal vascular fraction. Stem Cells Dev 2020;29:257-62.
               11.   Chu DT, Nguyen Thi Phuong T, Tien NLB, Tran DK, Minh LB, et al. Adipose tissue stem cells for therapy: an update on the progress of
                   isolation, culture, storage, and clinical application. J Clin Med 2019;8:917.
               12.   Lander EB, Berman MH. Autologous stromal vascular fraction: a new era of personal cell therapy. Stem Cells Res Dev Ther 2018;4:1-6.
               13.   Osteoarthritis Research Society International (OARSI) [Internet]. Available from: https://www.oarsi.org/ [Last accessed on 12 Jun 2020]
               14.   GBD Compare | IHME Viz Hub [Internet]. Available from: http://vizhub.healthdata.org/gbd-compare [Last accessed on 12 Jun 2020]
               15.   Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ 2003;81:646-56.
               16.   Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet 2019;393:1745-59.
               17.   Martel-Pelletier J, Barr AJ, Cicuttini FM, Conaghan PG, Cooper C, et al. Osteoarthritis. Nat Rev Dis Primer 2016;2:16072.
               18.   McAlindon TE, Bannuru RR, Sullivan MC, Arden NK, Berenbaum F, et al. OARSI guidelines for the non-surgical management of knee
                   osteoarthritis. Osteoarthritis Cartilage 2014;22:363-88.
               19.   Villalobos Córdoba FE, Izaguirre A, Almazan A, Cruz F, Pérez Jiménez FJ, et al. Articular cartilage injuries in 1,309 knee arthroscopies, a
                   public health problem in a developing country? Osteoarthritis Cartilage 2007;15:B102.
               20.   Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, et al. Treatment of deep cartilage defects in the knee with autologous
                   chondrocyte transplantation. N Engl J Med 1994;331:889-95.
               21.   Everhart JS, Campbell AB, Abouljoud MM, Kirven JC, Flanigan DC. Cost-efficacy of knee cartilage defect treatments in the United
                   States. Am J Sports Med 2019;363546519834557.
               22.   Orth P, Gao L, Madry H. Microfracture for cartilage repair in the knee: a systematic review of the contemporary literature. Knee Surg
                   Sports Traumatol Arthrosc 2020;28:670-706.
               23.   Thorlund JB, Juhl CB, Roos EM, Lohmander LS. Arthroscopic surgery for degenerative knee: systematic review and meta-analysis of
                   benefits and harms. BMJ 2015;350:h2747.
               24.   Lohmander LS, Hellot S, Dreher D, Krantz EFW, Kruger DS, et al. Intraarticular sprifermin (recombinant human fibroblast growth
                   factor 18) in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial: sprifermin effects in knee osteoarthritis. Arthritis
                   Rheumatol 2014;66:1820-31.
               25.   Zhang W, Ouyang H, Dass CR, Xu J. Current research on pharmacologic and regenerative therapies for osteoarthritis. Bone Res
                   2016;4:15040.
               26.   Poulet B, Staines KA. New developments in osteoarthritis and cartilage biology. Curr Opin Pharmacol 2016;28:8-13.
               27.   Wang AT, Feng Y, Jia HH, Zhao M, Yu H. Application of mesenchymal stem cell therapy for the treatment of osteoarthritis of the knee: a
                   concise review. World J Stem Cells 2019;11:222-35.
               28.   Ibarra C, Izaguirre A, Villalobos E, Masri M, Lombardero G, et al. Follow-up of a new arthroscopic technique for implantation of matrix-
                   encapsulated autologous chondrocytes in the knee. Arthrosc J Arthrosc Relat Surg 2014;30:715-23.
               29.   Villalobos E, Madrazo-Ibarra A, Martínez V, Olivos-Meza A, Velasquillo C, et al. Arthroscopic matrix-encapsulated autologous
                   chondrocyte implantation: a pilot multicenter investigation in Latin America. Cartilage 2020;11.
               30.   Brittberg M, Recker D, Ilgenfritz J, Saris DBF, Summit Extension Study Group. Matrix-applied characterized autologous cultured
                   chondrocytes versus microfracture: five-year follow-up of a prospective randomized trial. Am J Sports Med 2018;46:1343-51.
               31.   Schuette HB, Kraeutler MJ, McCarty EC. Matrix-assisted autologous chondrocyte transplantation in the knee: a systematic review of
                   mid- to long-term clinical outcomes. Orthop J Sports Med 2017;5:232596711770925.
               32.   MACI (Autologous Cultured Chondrocytes on a Porcine Collagen Membrane). Available from: https://www.fda.gov/vaccines-blood-
                   biologics/cellular-gene-therapy-products/maci-autologous-cultured-chondrocytes-porcine-collagen-membrane [Last accessed on 12 Jun
                   2020]
               33.   Okano T, Yamada N, Sakai H, Sakurai Y. A novel recovery system for cultured cells using plasma-treated polystyrene dishes grafted with
                   poly(N-isopropylacrylamide). J Biomed Mater Res 1993;27:1243-51.
               34.   Mitani G, Sato M, Lee JIK, Kaneshiro N, Ishihara M, et al. The properties of bioengineered chondrocyte sheets for cartilage regeneration.
                   BMC Biotechnol 2009;9:17.
               35.   Kaneshiro N, Sato M, Ishihara M, Mitani G, Sakai H,et al. Bioengineered chondrocyte sheets may be potentially useful for the treatment
                   of partial thickness defects of articular cartilage. Biochem Biophys Res Commun 2006;349:723-31.
               36.   Sato M, Yamato M, Hamahashi K, Okano T, Mochida J. Articular cartilage regeneration using cell sheet technology. Anat Rec (Hoboken)
                   2014;297:36-43.
               37.   Demoor M, Ollitrault D, Gomez-Leduc T, Bouyoucef M, Hervieu M, et al. Cartilage tissue engineering: Molecular control of chondrocyte
                   differentiation for proper cartilage matrix reconstruction. Biochim Biophys Acta 2014;1840:2414-40.
               38.   Barron V, Merghani K, Shaw G, Coleman CM, Hayes JS, et al. Evaluation of cartilage repair by mesenchymal stem cells seeded on a
                   PEOT/PBT scaffold in an osteochondral defect. Ann Biomed Eng 2015;43:2069-82.
               39.   Qi BW, Yu AX, Zhu SB, Zhou M, Wu G. Chitosan/poly(vinyl alcohol) hydrogel combined with Ad-hTGF-β1 transfected mesenchymal
                   stem cells to repair rabbit articular cartilage defects. Exp Biol Med 2013;238:23-30.
   334   335   336   337   338   339   340   341   342   343   344